Progranulin promotes functional recovery and neurogenesis in the subventricular zone of adult mice after cerebral ischemia. 2021

Yingxun Liu, and Junrong Ren, and Mengsi Kang, and Chenyang Zhai, and Qiangqiang Cheng, and Jin Li, and Yuzi Wu, and Xiaofei Ruan, and Jinlong Zhou, and Juan Fan, and Yingfang Tian
Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal University, Xi'an, Shaanxi 710062, China.

Progranulin (PGRN), a secreted glycosylated protein, has been reported to attenuate ischemia-induced cerebral injury through anti-inflammation, attenuation of blood-brain barrier disruption and neuroprotection. However, the effect of PGRN on neurogenesis in the subventricular zone (SVZ) after cerebral ischemia remains unclear. In this study, adult C57BL/6 mice were subjected to permanent middle cerebral artery occlusion (pMCAO), and different doses of recombinant mouse PGRN (r-PGRN, 0.3 ng, 1 ng, 5 ng) were intracerebroventricularly administered 30 min after pMCAO. Results showed that 1 ng r-PGRN markedly reduced infarct volume and rescued functional deficits 24 h after pMCAO. Meanwhile, 1 ng r-PGRN increased SVZ cell proliferation, as shown by a high number of bromodeoxyuridine-positive (BrdU+) cells and Ki-67+ cells in the ischemic ipsilateral SVZ 7 d after pMCAO. Additionally, PGRN increased the percentage of BrdU+/Doublecortin (DCX)+ cells in the ipsilateral SVZ 14 d after pMCAO and increased the percentage of new neurons (BrdU+/NeuN+ cells) in the peri-infarct striatum 28 d after pMCAO, suggesting that PGRN promotes neuronal differentiation. PGRN also upregulated phosphorylation of ERK1/2 and Akt in the ipsilateral SVZ 3 d after pMCAO. Our data indicate that PGRN treatment promotes acute functional recovery; most importantly, it also stimulates neurogenesis in the SVZ, which could be beneficial for long-term recovery after cerebral ischemia. The increase in neurogenesis could be associated with activation of the MAPK/ERK and PI3K/Akt pathways. These results suggest a potential new strategy utilizing PGRN in ischemic stroke therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral
D000077153 Progranulins Cysteine-rich, precursor glycoproteins encoded by the granulin gene (GRN). They contain granulin-repeats separated by linker sequences that are cleaved by a variety of proteases to release the individual GRANULIN PEPTIDES. The mammalian progranulin is composed of a half-granulin repeat followed by 7 granulin repeats. The mammalian GRANULINS are named PARAGRANULIN and granulin 1-7 for their order in the progranulin propeptide. Progranulin has growth-factor like effects and is expressed over a broad range of tissues. Under-expression of progranulin is linked to neurodegenerative diseases including FRONTOTEMPORAL DEMENTIA and NEURONAL CEROID LIPOFUSCINOSIS, while over-expression is linked to metabolic diseases including OBESITY, and INSULIN RESISTANCE. Acrogranin,Granulin Precursor,Granulin Precursor Protein,PC Cell-Derived Growth Factor,Proepithelin,Progranulin,PC Cell Derived Growth Factor
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D055495 Neurogenesis Formation of NEURONS which involves the differentiation and division of STEM CELLS in which one or both of the daughter cells become neurons. Neurogeneses
D019869 Phosphatidylinositol 3-Kinases Phosphotransferases that catalyzes the conversion of 1-phosphatidylinositol to 1-phosphatidylinositol 3-phosphate. Many members of this enzyme class are involved in RECEPTOR MEDIATED SIGNAL TRANSDUCTION and regulation of vesicular transport with the cell. Phosphatidylinositol 3-Kinases have been classified both according to their substrate specificity and their mode of action within the cell. PI-3 Kinase,Phosphatidylinositol-3-OH Kinase,PtdIns 3-Kinase,PI 3-Kinase,PI-3K,PI3 Kinases,PI3-Kinase,Phosphoinositide 3 Kinases,Phosphoinositide 3-Hydroxykinase,PtdIns 3-Kinases,3-Hydroxykinase, Phosphoinositide,Kinase, PI-3,Kinase, Phosphatidylinositol-3-OH,Kinases, PI3,Kinases, Phosphoinositide 3,PI 3 Kinase,PI3 Kinase,Phosphatidylinositol 3 Kinases,Phosphatidylinositol 3 OH Kinase,Phosphoinositide 3 Hydroxykinase,PtdIns 3 Kinase,PtdIns 3 Kinases

Related Publications

Yingxun Liu, and Junrong Ren, and Mengsi Kang, and Chenyang Zhai, and Qiangqiang Cheng, and Jin Li, and Yuzi Wu, and Xiaofei Ruan, and Jinlong Zhou, and Juan Fan, and Yingfang Tian
October 2007, Experimental neurology,
Yingxun Liu, and Junrong Ren, and Mengsi Kang, and Chenyang Zhai, and Qiangqiang Cheng, and Jin Li, and Yuzi Wu, and Xiaofei Ruan, and Jinlong Zhou, and Juan Fan, and Yingfang Tian
December 2010, Neuroscience,
Yingxun Liu, and Junrong Ren, and Mengsi Kang, and Chenyang Zhai, and Qiangqiang Cheng, and Jin Li, and Yuzi Wu, and Xiaofei Ruan, and Jinlong Zhou, and Juan Fan, and Yingfang Tian
April 2001, Proceedings of the National Academy of Sciences of the United States of America,
Yingxun Liu, and Junrong Ren, and Mengsi Kang, and Chenyang Zhai, and Qiangqiang Cheng, and Jin Li, and Yuzi Wu, and Xiaofei Ruan, and Jinlong Zhou, and Juan Fan, and Yingfang Tian
February 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Yingxun Liu, and Junrong Ren, and Mengsi Kang, and Chenyang Zhai, and Qiangqiang Cheng, and Jin Li, and Yuzi Wu, and Xiaofei Ruan, and Jinlong Zhou, and Juan Fan, and Yingfang Tian
June 2008, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Yingxun Liu, and Junrong Ren, and Mengsi Kang, and Chenyang Zhai, and Qiangqiang Cheng, and Jin Li, and Yuzi Wu, and Xiaofei Ruan, and Jinlong Zhou, and Juan Fan, and Yingfang Tian
September 2015, Neuroscience,
Yingxun Liu, and Junrong Ren, and Mengsi Kang, and Chenyang Zhai, and Qiangqiang Cheng, and Jin Li, and Yuzi Wu, and Xiaofei Ruan, and Jinlong Zhou, and Juan Fan, and Yingfang Tian
January 2017, BMC complementary and alternative medicine,
Yingxun Liu, and Junrong Ren, and Mengsi Kang, and Chenyang Zhai, and Qiangqiang Cheng, and Jin Li, and Yuzi Wu, and Xiaofei Ruan, and Jinlong Zhou, and Juan Fan, and Yingfang Tian
May 2022, CNS neuroscience & therapeutics,
Yingxun Liu, and Junrong Ren, and Mengsi Kang, and Chenyang Zhai, and Qiangqiang Cheng, and Jin Li, and Yuzi Wu, and Xiaofei Ruan, and Jinlong Zhou, and Juan Fan, and Yingfang Tian
January 2016, Evidence-based complementary and alternative medicine : eCAM,
Yingxun Liu, and Junrong Ren, and Mengsi Kang, and Chenyang Zhai, and Qiangqiang Cheng, and Jin Li, and Yuzi Wu, and Xiaofei Ruan, and Jinlong Zhou, and Juan Fan, and Yingfang Tian
May 2014, Neuroscience,
Copied contents to your clipboard!